Nan Fung Trinity’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-133,700
Closed -$9.17M 29
2024
Q2
$9.17M Buy
+133,700
New +$8.92M 1.98% 21
2020
Q1
Sell
-86,959
Closed -$5.65M 32
2019
Q4
$5.65M Buy
+86,959
New +$5.66M 1.08% 23

Other funds holding GILD

Nan Fung Trinity's GILD Position: Q3 2024 in Review

Nan Fung Trinity sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 133,700 shares — an estimated $9.17M sold.

Nan Fung Trinity first reported a position in GILD in Q4 2019 and held it in 2 quarters. The position peaked at $9.17M in Q2 2024. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Nan Fung Trinity reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Nan Fung Trinity sold 133,700 Gilead Sciences shares in Q3 2024, an estimated $9.17M.
  • Nan Fung Trinity first reported a position in Gilead Sciences in Q4 2019 and held it in 2 quarters.
  • Nan Fung Trinity's Gilead Sciences position peaked at $9.17M in Q2 2024.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Nan Fung Trinity's 13F filing for Q3 2024, filed 13 Nov 2024.